Baseline Therapeutics
2 known investors
Find your way into Baseline Therapeutics
Sign up to see every warm intro you have to Baseline Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Baseline Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Baseline is a biotech company focused on metabolism, obesity, incretins, and GLP-1-based strategies for substance use disorders, drawing on drug development and addiction medicine expertise. It develops therapies and brings drug candidates through clinical and regulatory pathways.
Investors · 2
Frequently asked questions
- What does Baseline Therapeutics do?
- Baseline is a biotech company focused on metabolism, obesity, incretins, and GLP-1-based strategies for substance use disorders, drawing on drug development and addiction medicine expertise. It develops therapies and brings drug candidates through clinical and regulatory pathways.
- Who are Baseline Therapeutics's investors?
- Baseline Therapeutics's investors include Very Serious Ventures, Versant Ventures.